Kidney Allograft Rejection and Coronavirus Disease 2019 Infection: A Narrative Review
- PMID: 37564455
- PMCID: PMC10410421
- DOI: 10.4103/abr.abr_167_22
Kidney Allograft Rejection and Coronavirus Disease 2019 Infection: A Narrative Review
Abstract
The world has experienced a global medical and socioeconomic burden following the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 is a systemic disease and may affect different organs including the kidneys. Current literature contains reports on COVID-19-related conditions such as acute kidney injury, and complications experienced by chronic kidney disease, end stage kidney disease, and kidney transplant patients. Here, we discuss the incidence of kidney allograft rejection, immunosuppression management and rejection risk, donor-specific antibodies and previous rejection episodes, and rejection outcomes in kidney transplant recipients with COVID-19 by reviewing current studies.
Keywords: Coronavirus; immunosuppression; kidney transplantation; rejection.
Copyright: © 2023 Advanced Biomedical Research.
Conflict of interest statement
There are no conflicts of interest.
References
-
- Asgharpour M, et al. COVID-19 and kidney disease: Update on epidemiology, clinical manifestations, pathophysiology and management. J Coll Physicians Surg Pak. 2020;30:19–25. - PubMed
Publication types
LinkOut - more resources
Full Text Sources